Copper Coordination Compounds as Biologically Active Agents
Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Coppe...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2020-05, Vol.21 (11), p.3965 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 11 |
container_start_page | 3965 |
container_title | International journal of molecular sciences |
container_volume | 21 |
creator | Krasnovskaya, Olga Naumov, Alexey Guk, Dmitry Gorelkin, Peter Erofeev, Alexander Beloglazkina, Elena Majouga, Alexander |
description | Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs.
Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action. |
doi_str_mv | 10.3390/ijms21113965 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32486510</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</originalsourceid><addsrcrecordid>eNpVkF9LwzAUxYMobk7ffJZ-AKs3SZM2CMJW_AcDX_Q5pEk6M9qmJN1g397KdMyney_33N-5HISuMdxRKuDerdtIMMZUcHaCpjgjJAXg-elRP0EXMa4BCCVMnKMJJVnBGYYpeih939uQlN4H4zo1ON-NQ9v7TWdiomKycL7xK6dV0-ySuR7c1ibzle2GeInOatVEe_VbZ-jz-emjfE2X7y9v5XyZ6ozBkBZVVeVcVARTjgtV21wInokM4_HjwlCwoMAw0IZpYQwnhNUV5oIowRQwRmfocc_tN1VrjR69g2pkH1yrwk565eT_Tee-5MpvZU4xAQoj4HYP0MHHGGx9uMUgf0KUxyGO8ptjv4P4LzX6DReFbek</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Copper Coordination Compounds as Biologically Active Agents</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Krasnovskaya, Olga ; Naumov, Alexey ; Guk, Dmitry ; Gorelkin, Peter ; Erofeev, Alexander ; Beloglazkina, Elena ; Majouga, Alexander</creator><creatorcontrib>Krasnovskaya, Olga ; Naumov, Alexey ; Guk, Dmitry ; Gorelkin, Peter ; Erofeev, Alexander ; Beloglazkina, Elena ; Majouga, Alexander</creatorcontrib><description>Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs.
Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.</description><identifier>ISSN: 1422-0067</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21113965</identifier><identifier>PMID: 32486510</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>Alzheimer Disease - drug therapy ; Amyloid beta-Peptides - chemistry ; Animals ; Anti-Infective Agents - therapeutic use ; Antineoplastic Agents - therapeutic use ; Biological Factors - chemistry ; Cell Line, Tumor ; Copper - chemistry ; Drug Design ; Drug Evaluation, Preclinical ; Flow Cytometry ; HEK293 Cells ; Humans ; Inhibitory Concentration 50 ; Ions ; Isotopes - chemistry ; Ligands ; MCF-7 Cells ; Mycobacterium tuberculosis ; Oxidation-Reduction ; Positron-Emission Tomography ; Review ; Spectrophotometry ; Tetrazolium Salts - pharmacology ; Thiazoles - pharmacology ; Tuberculosis - drug therapy</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (11), p.3965</ispartof><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</citedby><cites>FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</cites><orcidid>0000-0002-4860-9013 ; 0000-0002-5674-8654</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312030/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312030/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32486510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krasnovskaya, Olga</creatorcontrib><creatorcontrib>Naumov, Alexey</creatorcontrib><creatorcontrib>Guk, Dmitry</creatorcontrib><creatorcontrib>Gorelkin, Peter</creatorcontrib><creatorcontrib>Erofeev, Alexander</creatorcontrib><creatorcontrib>Beloglazkina, Elena</creatorcontrib><creatorcontrib>Majouga, Alexander</creatorcontrib><title>Copper Coordination Compounds as Biologically Active Agents</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs.
Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.</description><subject>Alzheimer Disease - drug therapy</subject><subject>Amyloid beta-Peptides - chemistry</subject><subject>Animals</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biological Factors - chemistry</subject><subject>Cell Line, Tumor</subject><subject>Copper - chemistry</subject><subject>Drug Design</subject><subject>Drug Evaluation, Preclinical</subject><subject>Flow Cytometry</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Ions</subject><subject>Isotopes - chemistry</subject><subject>Ligands</subject><subject>MCF-7 Cells</subject><subject>Mycobacterium tuberculosis</subject><subject>Oxidation-Reduction</subject><subject>Positron-Emission Tomography</subject><subject>Review</subject><subject>Spectrophotometry</subject><subject>Tetrazolium Salts - pharmacology</subject><subject>Thiazoles - pharmacology</subject><subject>Tuberculosis - drug therapy</subject><issn>1422-0067</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkF9LwzAUxYMobk7ffJZ-AKs3SZM2CMJW_AcDX_Q5pEk6M9qmJN1g397KdMyney_33N-5HISuMdxRKuDerdtIMMZUcHaCpjgjJAXg-elRP0EXMa4BCCVMnKMJJVnBGYYpeih939uQlN4H4zo1ON-NQ9v7TWdiomKycL7xK6dV0-ySuR7c1ibzle2GeInOatVEe_VbZ-jz-emjfE2X7y9v5XyZ6ozBkBZVVeVcVARTjgtV21wInokM4_HjwlCwoMAw0IZpYQwnhNUV5oIowRQwRmfocc_tN1VrjR69g2pkH1yrwk565eT_Tee-5MpvZU4xAQoj4HYP0MHHGGx9uMUgf0KUxyGO8ptjv4P4LzX6DReFbek</recordid><startdate>20200531</startdate><enddate>20200531</enddate><creator>Krasnovskaya, Olga</creator><creator>Naumov, Alexey</creator><creator>Guk, Dmitry</creator><creator>Gorelkin, Peter</creator><creator>Erofeev, Alexander</creator><creator>Beloglazkina, Elena</creator><creator>Majouga, Alexander</creator><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4860-9013</orcidid><orcidid>https://orcid.org/0000-0002-5674-8654</orcidid></search><sort><creationdate>20200531</creationdate><title>Copper Coordination Compounds as Biologically Active Agents</title><author>Krasnovskaya, Olga ; Naumov, Alexey ; Guk, Dmitry ; Gorelkin, Peter ; Erofeev, Alexander ; Beloglazkina, Elena ; Majouga, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-8bbb769b213618afe7996494119658d30e0a0d50cd5c9dd6225fb1692a95a0553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Alzheimer Disease - drug therapy</topic><topic>Amyloid beta-Peptides - chemistry</topic><topic>Animals</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biological Factors - chemistry</topic><topic>Cell Line, Tumor</topic><topic>Copper - chemistry</topic><topic>Drug Design</topic><topic>Drug Evaluation, Preclinical</topic><topic>Flow Cytometry</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Ions</topic><topic>Isotopes - chemistry</topic><topic>Ligands</topic><topic>MCF-7 Cells</topic><topic>Mycobacterium tuberculosis</topic><topic>Oxidation-Reduction</topic><topic>Positron-Emission Tomography</topic><topic>Review</topic><topic>Spectrophotometry</topic><topic>Tetrazolium Salts - pharmacology</topic><topic>Thiazoles - pharmacology</topic><topic>Tuberculosis - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krasnovskaya, Olga</creatorcontrib><creatorcontrib>Naumov, Alexey</creatorcontrib><creatorcontrib>Guk, Dmitry</creatorcontrib><creatorcontrib>Gorelkin, Peter</creatorcontrib><creatorcontrib>Erofeev, Alexander</creatorcontrib><creatorcontrib>Beloglazkina, Elena</creatorcontrib><creatorcontrib>Majouga, Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krasnovskaya, Olga</au><au>Naumov, Alexey</au><au>Guk, Dmitry</au><au>Gorelkin, Peter</au><au>Erofeev, Alexander</au><au>Beloglazkina, Elena</au><au>Majouga, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copper Coordination Compounds as Biologically Active Agents</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-31</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>3965</spage><pages>3965-</pages><issn>1422-0067</issn><eissn>1422-0067</eissn><abstract>Copper-containing coordination compounds attract wide attention due to the redox activity and biogenicity of copper ions, providing multiple pathways of biological activity. The pharmacological properties of metal complexes can be fine-tuned by varying the nature of the ligand and donor atoms. Copper-containing coordination compounds are effective antitumor agents, constituting a less expensive and safer alternative to classical platinum-containing chemotherapy, and are also effective as antimicrobial, antituberculosis, antimalarial, antifugal, and anti-inflammatory drugs.
Сu-labeled coordination compounds are promising PET imaging agents for diagnosing malignant pathologies, including head and neck cancer, as well as the hallmark of Alzheimer's disease amyloid-β (Aβ). In this review article, we summarize different strategies for possible use of coordination compounds in the treatment and diagnosis of various diseases, and also various studies of the mechanisms of antitumor and antimicrobial action.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>32486510</pmid><doi>10.3390/ijms21113965</doi><orcidid>https://orcid.org/0000-0002-4860-9013</orcidid><orcidid>https://orcid.org/0000-0002-5674-8654</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2020-05, Vol.21 (11), p.3965 |
issn | 1422-0067 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312030 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central |
subjects | Alzheimer Disease - drug therapy Amyloid beta-Peptides - chemistry Animals Anti-Infective Agents - therapeutic use Antineoplastic Agents - therapeutic use Biological Factors - chemistry Cell Line, Tumor Copper - chemistry Drug Design Drug Evaluation, Preclinical Flow Cytometry HEK293 Cells Humans Inhibitory Concentration 50 Ions Isotopes - chemistry Ligands MCF-7 Cells Mycobacterium tuberculosis Oxidation-Reduction Positron-Emission Tomography Review Spectrophotometry Tetrazolium Salts - pharmacology Thiazoles - pharmacology Tuberculosis - drug therapy |
title | Copper Coordination Compounds as Biologically Active Agents |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A56%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copper%20Coordination%20Compounds%20as%20Biologically%20Active%20Agents&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Krasnovskaya,%20Olga&rft.date=2020-05-31&rft.volume=21&rft.issue=11&rft.spage=3965&rft.pages=3965-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21113965&rft_dat=%3Cpubmed_cross%3E32486510%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32486510&rfr_iscdi=true |